Beijing Bohui boasts strong independent R&D capabilities and has established a professional R&D team. Through continuous technological innovation, it has developed five major technical platforms: molecular diagnosis, immunoassay, atomic absorption, atomic fluorescence, and mass spectrometry. The company has successfully industrialized products based on these technical platforms. Among them, the human trace element detection system has been widely used in more than 7,000 hospitals across the country, with an annual detection volume of up to 22 million person-times. The fully automated nucleic acid testing system developed by the company using advanced microfluidic chip technology, hailed as a "laboratory on a chip", serves a wide range of medical and health institutions.